tiprankstipranks
Trending News
More News >
Burcon Nutrascience (TSE:BU)
TSX:BU

Burcon Nutrascience (BU) Price & Analysis

Compare
76 Followers

BU Stock Chart & Stats

C$1.73
C$0.00(0.00%)
At close: 4:00 PM EST
C$1.73
C$0.00(0.00%)

Bulls Say, Bears Say

Bulls Say
IP-driven Monetization ModelBurcon’s business model emphasizes licensing, ingredient sales and milestone fees tied to its plant-protein technologies. This IP-led approach is capital-light versus manufacturing, enabling scalable revenue streams if partners commercialize products and adopt its technologies over the medium term.
Asset-light R&D OrganizationA small headcount reflects an asset-light, R&D-centric organization focused on technology and IP rather than large-scale manufacturing. Low fixed-cost structure supports runway and scalability of licensing/royalty economics, helping preserve capital while pursuing partner-led commercialization.
Improving Cash-flow TrendFree cash flow has moved in a less negative direction and FCF exceeds net income on a relative basis, indicating improving cash conversion. If sustained, this trend reduces reliance on external funding and improves the company’s ability to finance development and partner engagements over coming quarters.
Bears Say
Negative Gross Profit And Extreme LossesPersistent negative gross profit and extreme net losses signal that core product economics are currently unviable. Without meaningful margin improvement through cost reductions, yield gains, pricing, or partner economics, the business cannot sustainably scale revenue into profitability over the medium term.
Severely Strained Balance SheetVery high leverage and eroded equity materially constrain strategic flexibility. Heavy debt burdens increase refinancing risk and can force dilutive capital raises or restrict investment in commercialization, slowing the company’s ability to convert technology into recurring licensing or ingredient revenues.
Small, Inconsistent Revenue BaseDespite a recent TTM rebound, historical revenues are small and uneven, indicating fragile commercial traction. Dependence on sporadic partner milestones and inconsistent sales makes future royalties and ingredient volumes unpredictable, raising execution risk for sustainable growth and operating leverage.

Burcon Nutrascience News

BU FAQ

What was Burcon Nutrascience’s price range in the past 12 months?
Burcon Nutrascience lowest stock price was C$1.50 and its highest was C$5.00 in the past 12 months.
    What is Burcon Nutrascience’s market cap?
    Burcon Nutrascience’s market cap is C$25.26M.
      When is Burcon Nutrascience’s upcoming earnings report date?
      Burcon Nutrascience’s upcoming earnings report date is Jul 01, 2026 which is in 133 days.
        How were Burcon Nutrascience’s earnings last quarter?
        Burcon Nutrascience released its earnings results on Feb 11, 2026. The company reported -C$0.28 earnings per share for the quarter, missing the consensus estimate of C$0 by -C$0.28.
          Is Burcon Nutrascience overvalued?
          According to Wall Street analysts Burcon Nutrascience’s price is currently Overvalued. Get more investment ideas with TipRanks Premium
            Does Burcon Nutrascience pay dividends?
            Burcon Nutrascience does not currently pay dividends.
            What is Burcon Nutrascience’s EPS estimate?
            Burcon Nutrascience’s EPS estimate is -0.1.
              How many shares outstanding does Burcon Nutrascience have?
              Burcon Nutrascience has 12,692,276 shares outstanding.
                What happened to Burcon Nutrascience’s price movement after its last earnings report?
                Burcon Nutrascience reported an EPS of -C$0.28 in its last earnings report, missing expectations of C$0. Following the earnings report the stock price went up 1.596%.
                  Which hedge fund is a major shareholder of Burcon Nutrascience?
                  Currently, no hedge funds are holding shares in TSE:BU
                  What is the TipRanks Smart Score and how is it calculated?
                  Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology

                    Company Description

                    Burcon Nutrascience

                    Burcon NutraScience Corporation, together with its subsidiaries, develops plant proteins and ingredients for use in the food and beverage industries in Canada. The company's products include Peazazz, a pea protein for use in dairy alternatives, ready-to-drink beverages, dry blended beverages, bars, baked goods, and meat substitute products; and Peazac and Peazac 850, a pea protein for plant-based meat alternative products, ready-to-mix powders, ready-to-mix beverages, dairy alternatives, and nutrition bars, as well as other applications requiring the most neutral flavor and moderate viscosity. It provides Puratein, a canola protein isolate for use in meat alternatives, such as burgers, sausages, and nutrition bars; Supertein, a canola protein that is a light-colored powder for use in non-dairy frozen desserts, egg alternative, plant-based marshmallows and ready-to-mix beverages, whipped toppings, and plant-based bars; and Nutratein, a canola protein comprising a mixture of globulin and albumin proteins for use in meat and egg alternatives, and other plant-based functional foods. In addition, the company offers Nutratein-PS and Nutratein-TZ, a blend of Peazac pea protein; and CLARISOY, a soy protein for use in sports nutrition beverages, citrus-based drinks, fruit-flavored beverages, lemonades, powdered beverage mixes, and other foods and nutritional products. Further, it provides MeritPro, a nutritional protein blend, including allergen-free, gluten-free, non-dairy, non-GMO, and vegan. The company was formerly known as Burcon Capital Corp. and changed its name to Burcon NutraScience Corporation in October 1999. The company was incorporated in 1998 and is headquartered in Vancouver, Canada.

                    Burcon Nutrascience (BU) Earnings & Revenues

                    BU Earnings Call

                    Q3 2026
                    0:00 / 0:00
                    Earnings Call Sentiment|Positive
                    The earnings call highlighted significant progress in production capabilities, customer engagement, and strategic agreements, with some concerns about onetime start-up costs. The overall tone was optimistic, focusing on execution and future growth potential.View all TSE:BU earnings summaries
                    Similar Stocks
                    Company
                    Price & Change
                    Follow
                    DAVIDsTEA
                    Else Nutrition Holdings
                    Nepra Foods
                    Cult Food Science Corp.
                    Pangea Natural Food, Inc.
                    Popular Stocks